Godavari Biorefineries Q1 FY27: Key Estimates 2026

Stock snapshot ahead of the print

Godavari Biorefineries is moving into the July-August 2026 results window with its shares trading at Rs.266. At this price, the company is valued at a market capitalisation of Rs.1,353 crore. The stated price-to-earnings multiple is “not meaningful”, reflecting the volatility in profitability across recent periods. Investor positioning is increasingly focused on how Q1 FY27 trends compare with the swing in earnings seen in Q4 FY26. The quarter ended June 2026 is also important because some of the company’s segments are seasonal in nature, which can influence quarterly comparisons. Against this backdrop, the market is watching both the revenue trajectory and the extent of profitability normalization.

When are Godavari Biorefineries Q1 FY27 results expected?

Godavari Biorefineries’ Q1 FY27 results are expected in the July-August 2026 window, consistent with the broader NSE and BSE results season for the quarter ending June 2026. The company has also scheduled an earnings conference call for Q1 FY27 at 11:00 AM IST on Friday, 7 August 2026. The call is intended to discuss the company’s financial and operational performance for the quarter ended 30 June 2026. The scheduled speakers include Chairman and Managing Director Samir Somaiya and AGM, Investor Relations and Finance Ashish Sinha. In a separate regulatory communication, the company stated that its board approved the unaudited standalone and consolidated financial results for the first quarter ended 30 June 2026, along with the limited review report and a press release.

Q1 FY27 revenue and PAT estimates in focus

The trailing-growth estimate for Godavari Biorefineries’ Q1 FY27 revenue is Rs.481-553 crore. This estimate is built using a Q1 FY26 base of Rs.534 crore and the most recent year-on-year growth signal referenced from Q4 FY26. On profitability, the PAT estimate range is Rs.-10 to -13 crore for Q1 FY27. The comparison base cited for Q1 FY26 is a net loss of Rs.-16 crore. The preview framework in the provided data explicitly positions these estimates as a range rather than a point forecast.

Estimate table: Q1 FY27E versus Q1 FY26

What the latest reported quarter (Q4 FY26) indicates

Ahead of Q1 FY27, the most recent reported quarter cited is Q4 FY26, when total income was Rs.570 crore. For that quarter ended 31 March 2026, the company posted net profit of Rs.52.9 crore, compared with Rs.71.9 crore in the same quarter of the previous year. EBITDA in Q4 FY26 was Rs.92.1 crore, while EBITDA margin contracted to 16.2% from 20.7% a year ago. These figures matter because the Q4 FY26 outcome is referenced as the base against which the Q1 FY27 estimates in the preview are constructed. It also highlights that quarterly profitability can shift sharply depending on mix and margins.

Q1 FY26 base: seasonal context and operating highlights

For Q1 FY26, the company reported total income of Rs.534.0 crore, EBITDA of Rs.6.5 crore, and PAT of Rs.-16.0 crore on a consolidated basis. The company also flagged that some segments are seasonal and can influence results in specific quarters. A notable mix indicator shared was that revenue from Bio-based chemicals and Ethanol increased to 65% in Q1 FY26 compared with 54% in Q1 FY25. Management commentary also highlighted that Q1 FY26 saw a turnaround in EBITDA versus the same period last year, supported by product mix and lower interest costs. The company stated that gross margin expanded by 512 basis points year-on-year to 19% in that quarter.

FY26 profitability turnaround and full-year revenue

On an annual basis, Godavari Biorefineries returned to profitability in FY26 with a net profit of Rs.3.5 crore, versus a net loss of Rs.23.4 crore in FY25. Revenue from operations for FY26 stood at Rs.1,987.9 crore, up 6.3% from Rs.1,870.3 crore in FY25. The audited standalone and consolidated financial results were approved by the board on 22 May 2026 and published in newspapers on 24 May 2026, as per disclosures made under SEBI listing regulations. These full-year numbers provide a broader backdrop for Q1 FY27, showing improved profitability at the annual level even as quarterly results remain uneven.

Balance sheet and cost cues cited by the company

The company disclosed that Rs.240 crore of term debt was repaid through IPO proceeds, contributing to a reduction in finance costs. In the Q1 FY26 performance highlights, finance cost was shown at Rs.15.3 crore versus Rs.19.6 crore in Q1 FY25. Additional commentary referenced a 22% drop in interest expenses compared to the previous year. Operationally, the ethanol segment was cited as facing an EBITDA margin reduction of around 2% due to off-season maintenance activities. At the same time, the bio-based chemical division was described as delivering a 43% rise in EBITDA, indicating an improving contribution from the specialty chemistry side of the portfolio.

Valuation and target range: what the numbers imply

Godavari Biorefineries trades at Rs.266 versus a 12-month Uniresearch target range of Rs.245-279. The stated target range is framed as a tracking stance, rather than a directional call in the provided data. The current market price sits within the stated target band, which typically implies limited implied upside or downside based purely on that estimate range. With the P/E described as not meaningful, investors are likely to anchor on revenue stability, margin movement, and management commentary on segment mix and finance costs.

Market impact: what investors are likely to track

The most direct market inputs in the data are the Q1 FY27 revenue and PAT estimate ranges, the Q4 FY26 margin contraction, and the company’s FY26 return to profitability. Any divergence from the Rs.481-553 crore revenue range could shift near-term expectations, especially given the Q1 FY26 base of Rs.534 crore. On earnings, the estimated PAT loss range of Rs.-10 to -13 crore is set against Q1 FY26’s Rs.-16 crore loss, keeping attention on whether losses narrow meaningfully. The scheduled 7 August 2026 earnings call provides a clear forum for investors to assess operational drivers, including seasonal effects, ethanol maintenance impacts, and bio-based chemical performance.

Conclusion

Godavari Biorefineries heads into Q1 FY27 results season with the stock at Rs.266 and estimates pointing to revenue of Rs.481-553 crore and PAT of Rs.-10 to -13 crore. The company’s recent history includes a profitable Q4 FY26, a full-year FY26 return to profit, and a stated improvement in finance costs after debt repayment. Investors will look for the confirmed Q1 FY27 numbers and management’s operational commentary when the company discusses results on 7 August 2026.